SCHEMBL6406531

SCHEMBL6406531

O=C(NS(=O)(=O)c1ccccc1)c1cn2nc(Br)cc(Cl)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.49
PTGS1 P23219 5/20 0.49
FLT1 P17948 7/20 0.47
FLT4 P35916 7/20 0.47
KDR P35968 7/20 0.47
KMO O15229 1/20 0.44
EGFR P00533 2/20 0.43
ALKBH2 Q6NS38 1/20 0.43
ALKBH5 Q6P6C2 1/20 0.43
FTO Q9C0B1 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIK1 P39086 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42
GRIA4 P48058 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15133392 0.87 EGFR (0.50) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL6405765 0.86 PTGS2 (0.48) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL10204174 0.81 FLT1 (0.53) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL6406548 0.79 PTGS2 (0.53) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL6400785 0.77 PTGS2 (0.51) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL15625176 0.76 PTGS2 (0.50) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL10204203 0.74 NPC1 (0.52) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL10204175 0.74 PTGS2 (0.52) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL6412571 0.73 PTGS2 (0.51) PTGS2PTGS1FLT1FLT4KDR
SCHEMBL10204167 0.72 PTGS2 (0.50) PTGS2PTGS1EGFRALKBH2ALKBH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023850-B2 Nematocidal sulfonamides E I DU PONT DE NEMOURS AND COMPANY (US) 2015-05-05 US disclosed
US-9023850-B2 Nematocidal sulfonamides E I DU PONT DE NEMOURS AND COMPANY (US) 2015-05-05 US disclosed
US-20130190172-A1 NEMATOCIDAL SULFONAMIDES E I DU PONT DE NEMOURS AND COMPANY (US) 2013-07-25 US disclosed
US-20130190172-A1 NEMATOCIDAL SULFONAMIDES E I DU PONT DE NEMOURS AND COMPANY (US) 2013-07-25 US disclosed
WO-2012054233-A1 NEMATOCIDAL SULFONAMIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190172-A1 NEMATOCIDAL SULFONAMIDES QSOX1, ARSA, NOX1 PTGS2 995/4885PTGS1 304/4885FLT1 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.